Skip to content

Salud Mental

ISSN 0185-3325

2 papers in the library · 20 citations · publishing 2014-2017

Papers

An approach to the new psychoactive drugs phenomenon

Salud Mental April 3, 2017 Helen Dolengevich-Segal, Beatriz Rodríguez-salgado, Jorge Gómez-arnau et al. 16 citations

New psychoactive drugs (NPD) are substances that pose a public health danger but are not yet prohibited by international narcotics conventions; the concept also includes novel consumption contexts, routes, and distribution methods, especially via the Internet. Risks associated with NPD use are largely unknown to users and healthcare providers. This review integrates existing evidence on the description, epidemiology, psychopharmacology, medical complications, and psychoactive effects of the most relevant NPD: synthetic cannabinoids, synthetic cathinones, NBOMe series, indoleamines, piperazines, hallucinogenic mushrooms, synthetic opioids, plant products (khat, kratom, Salvia divinorum, ayahuasca), and dissociative anesthetics. The emergence of NPD is a rising phenomenon with important public health consequences, and medical professionals should learn about new consumption trends and potential risks.

DOI: 10.17711/sm.0185-3325.2017.010 MDMA Mephedrone Psychoactive substance Psychoactive drug +9

Salvia divinorum: enigma psicofarmacológico y resquicio mente-cuerpo

Salud Mental January 1, 2014 J. Díaz 4 citations

A multidisciplinary analysis of Salvia divinorum and its main active principle, salvinorin A, examines whether the plant's ethnobotany, phytochemistry, and pharmacology can explain its experienced effects and traditional divinatory uses. Field research from 1973-1983 documented that a water potion of crushed leaves produced short-lasting light-headedness, dysphoria, tactile and proprioceptive sensations, depersonalization, amplified sound perception, and increased visual and auditory imagery, but no actual hallucinations. Similar effects were attributed to salvinorin A, but cannot be explained solely by its potent brain kappa-opioid receptor agonist activity. The paper proposes requirements for classifying consciousness-altering substances and suggests top-down analyses of neural networks to explore differential ethnic effects.

DOI: 10.17711/sm.0185-3325.2014.022 Full text Psychology Medicine